SlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19A Report on The Progress Towards Ending HIV - Nicole Seguy, MD, MPHView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19The Georgian Model for Hepatitis C Elimination (With Reflection on the Impact of COVID-19 Pandemic) - Tengiz Tsertsvadze, MD, PHDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19EASL Guidelines on Viral Hepatitis Elimination - Mojca Matičič, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19Update on the Use of Generic Drugs for HIV in Europe - Liudmyla MaistatView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19Rollout of PrEP in Europe: Success Stories and Challenges - Teymur Noori, MScView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19Long-Acting Therapy for PrEP: How Will We Use it? - Luis MendãoView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19HIV Prevention in High Risk Populations: Unique Challenges and Solutions - Jean-Michel Molina, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19Update on COVID-19 Therapeutics - Daniel Kuritzkes, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19SARS-CoV-2 Antibody Seroprevalence in Previously Undiagnosed Persons in Tbilisi, Georgia: Results of Three Repeated Serosurveys - Akaki AbutidzeView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19Dynamics and Peculiarities of AIDS Mortality in Minsk, Belarus - Shylava, MarharytaView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCOVID-19COVID-19 Challenges and Scale-up in Access to Community-Based HCV Treatment for HIV/HCV Co-infected PWIDs in Ukraine - Zahedul IslamView Slideset
